Musalea
Español Sign in

Terms of use

The terms of your Musalea account, the free trial and the app on your computers. Musalea is provided by Integrated Biopharma Strategy S.L. (see the Legal notice). By using your account or the app, you accept these terms.

Your account

The free trial

Paid plans

After the trial, a paid plan keeps everything open. Its price, length and conditions are shown to you before you pay, and become part of these terms.

The app on your computers

Your own scores

The Method's content

Acceptable use

Do not use Musalea to break the law or anyone's rights; do not upload harmful files or content you have no right to use; do not try to reach other accounts or data; and do not overload, probe or disrupt the service, or download its content by automated means.

The service

We work to keep the service available and to improve it, so features may change. Preparing scores, the Method's downloads and licence renewals need our server; what the app has already downloaded works offline while your licence is valid.

Liability

We provide Musalea with reasonable care and skill. We are not liable for indirect losses or for losses caused by events outside our control. Nothing in these terms limits liability that the law does not allow to be limited, nor your rights as a consumer under the law of your country.

Ending

You can stop using Musalea at any time, and ask us to close your account by writing to contact@inbistra.com. We may close an account that seriously or repeatedly breaks these terms.

Changes to these terms

When we change these terms, we publish the new version here with its date. A change that affects you materially applies once you have had the chance to read it; if you do not accept it, you can stop using Musalea.

Law and jurisdiction

These terms are governed by Spanish law. If you are a consumer, you keep the protection of the mandatory law of the country where you live, and you may go to the courts of your place of residence. Write to us first: most questions are solved quickly by email.

Last updated: 6 November 2026.